Olgu Sunumu
BibTex RIS Kaynak Göster

Eruptive Xanthoma During Antiretroviral Therapy

Yıl 2019, , 43 - 45, 15.03.2019
https://doi.org/10.5799/jmid.537168

Öz

We
present a case of eruptive xanthoma in a man living with HIV after changing
antiretroviral therapy. People living with HIV are at increased risk of
dyslipidemia due to the infection itself and the use of antiretroviral
medications. Prompt recognition of eruptive xanthomas may allow for timely
diagnosis of metabolic disorders and dyslipidemia in patients being treated for
HIV infection
J Microbiol Infect Dis 2019; 9(1): 43-45.

Kaynakça

  • 1. Kashif M, Kumar H, Khaja M. An Unusual Presentation of Eruptive Xanthoma: A Case Report and Literature Review. Ed. Sergio Gonzalez Bombardiere. Medicine 2016; 95(37): e4866. 2. da Cunha J, Maselli LM, Stern AC, Spada C, Bydlowski SP. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs. World J Virol 2015; 4(2): 56-77. 3. Campbell SM, Crowe SM, Mak J. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 2002; 16(17):2253-2261. 4. Tivicay Dolutegravir (as dolutegravir sodium). Laval, Quebec, Canada: ViiV Healthcare ULC; February 2017. 5. Quercia R, Roberts J, Martin-Carpenter L, Zala C. Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks. Clin Drug Investig 2015; 35(3): 211-219.
Yıl 2019, , 43 - 45, 15.03.2019
https://doi.org/10.5799/jmid.537168

Öz

Kaynakça

  • 1. Kashif M, Kumar H, Khaja M. An Unusual Presentation of Eruptive Xanthoma: A Case Report and Literature Review. Ed. Sergio Gonzalez Bombardiere. Medicine 2016; 95(37): e4866. 2. da Cunha J, Maselli LM, Stern AC, Spada C, Bydlowski SP. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs. World J Virol 2015; 4(2): 56-77. 3. Campbell SM, Crowe SM, Mak J. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 2002; 16(17):2253-2261. 4. Tivicay Dolutegravir (as dolutegravir sodium). Laval, Quebec, Canada: ViiV Healthcare ULC; February 2017. 5. Quercia R, Roberts J, Martin-Carpenter L, Zala C. Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks. Clin Drug Investig 2015; 35(3): 211-219.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Olgu Sunumu
Yazarlar

Olushola L. Akinshemoyin Vaughn Bu kişi benim

Kenneth B. Gordon Bu kişi benim

J. Njeri Wainaina Bu kişi benim

Yayımlanma Tarihi 15 Mart 2019
Yayımlandığı Sayı Yıl 2019

Kaynak Göster

APA Vaughn, O. L. A., Gordon, K. B., & Wainaina, J. N. (2019). Eruptive Xanthoma During Antiretroviral Therapy. Journal of Microbiology and Infectious Diseases, 09(01), 43-45. https://doi.org/10.5799/jmid.537168
AMA Vaughn OLA, Gordon KB, Wainaina JN. Eruptive Xanthoma During Antiretroviral Therapy. J Microbil Infect Dis. Mart 2019;09(01):43-45. doi:10.5799/jmid.537168
Chicago Vaughn, Olushola L. Akinshemoyin, Kenneth B. Gordon, ve J. Njeri Wainaina. “Eruptive Xanthoma During Antiretroviral Therapy”. Journal of Microbiology and Infectious Diseases 09, sy. 01 (Mart 2019): 43-45. https://doi.org/10.5799/jmid.537168.
EndNote Vaughn OLA, Gordon KB, Wainaina JN (01 Mart 2019) Eruptive Xanthoma During Antiretroviral Therapy. Journal of Microbiology and Infectious Diseases 09 01 43–45.
IEEE O. L. A. Vaughn, K. B. Gordon, ve J. N. Wainaina, “Eruptive Xanthoma During Antiretroviral Therapy”, J Microbil Infect Dis, c. 09, sy. 01, ss. 43–45, 2019, doi: 10.5799/jmid.537168.
ISNAD Vaughn, Olushola L. Akinshemoyin vd. “Eruptive Xanthoma During Antiretroviral Therapy”. Journal of Microbiology and Infectious Diseases 09/01 (Mart 2019), 43-45. https://doi.org/10.5799/jmid.537168.
JAMA Vaughn OLA, Gordon KB, Wainaina JN. Eruptive Xanthoma During Antiretroviral Therapy. J Microbil Infect Dis. 2019;09:43–45.
MLA Vaughn, Olushola L. Akinshemoyin vd. “Eruptive Xanthoma During Antiretroviral Therapy”. Journal of Microbiology and Infectious Diseases, c. 09, sy. 01, 2019, ss. 43-45, doi:10.5799/jmid.537168.
Vancouver Vaughn OLA, Gordon KB, Wainaina JN. Eruptive Xanthoma During Antiretroviral Therapy. J Microbil Infect Dis. 2019;09(01):43-5.